Julie Beck

March 27, 2013 | Inside Counsel

Yesterday U.S. Magistrate Judge Leslie G. Foschio issued a report in which she recommended that Paul Ceglias claims that he and Mark Zuckerberg are co-owners of Facebook be thrown out, because the evidence hes based his lawsuit on is fraudulent.

By Julie Beck

3 minute read

March 26, 2013 | Inside Counsel

A Spanish open-source software group is hoping that the European Union will stand up to big, bad Microsoftagain.

By Julie Beck

2 minute read

March 25, 2013 | Corporate Counsel

Stored Communications Act doesnt protect cell phone contents; CEO who caused company bankruptcy needs longer prison sentence; Customer can sue for emotional distress over uneaten contaminated food; Externs not employees under FLSA

By Julie Beck

4 minute read

March 25, 2013 | Corporate Counsel

Courts, companies, law firms, legal services organizations and bar associations all have their roles to play when it comes to providing pro bono legal aid to low-income citizens.

By Julie Beck

7 minute read

March 25, 2013 | Corporate Counsel

The 1st Circuit issued a precedential ruling on Jan. 17, creating a circuit split when it found that the risk of relapsing back into an addiction constitutes a current disability in <em>Colby v. Union Security Insurance Company</em>.

By Julie Beck

9 minute read

March 25, 2013 | Inside Counsel

Compounding pharmacies across the country are likely having flashbacks to mean high school teachers who would give the whole class extra homework to punish one students misconduct.

By Julie Beck

2 minute read

March 22, 2013 | Inside Counsel

Bayer AGs contraceptive products have really been under fire lately.

By Julie Beck

2 minute read

March 21, 2013 | Inside Counsel

Monks these days are so ambitious.

By Julie Beck

2 minute read

March 21, 2013 | Inside Counsel

The era when protecting consumer privacy was a simple matter is long gone.

By Julie Beck, Mary Swanton

9 minute read

March 20, 2013 | Inside Counsel

Earlier this month, Bayer AG designated $1.5 billion for litigation related to its Yasmin and Yaz contraceptive pills, and now it looks like the company will be dipping into that fund.

By Julie Beck

4 minute read